FRET Antibody Assay for C3 Convertase Activity Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying the complement system, particularly the alternative pathway, are low throughput and unreliable, making it difficult to detect and measure key components like C3 convertase and its regulators, which hinders the development of new drugs and biomarker discovery for complement-mediated diseases.
Innovation Solution
A high-throughput method using FRET (Fluorescence Resonance Energy Transfer) with specifically designed antibody pairs to detect C3a and C3 in biological samples, allowing for quantification by comparing signals to standard curves, enabling reliable measurement of protease activity and component production over time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If Western blotting or ELISA methods are used to detect C3 and C3a, then detection capability is provided, but throughput is low and labor is high
Solution Approach 1:
The patent replaces manual mechanical detection methods (Western blotting, ELISA) with an automated FRET-based fluorescence detection system. The FRET assay uses fluorescently labeled antibodies and resonance energy transfer to automatically quantify C3 and C3a levels, eliminating the need for manual protein transfer, staining, and analysis steps, thereby dramatically increasing throughput while maintaining measurement precision
Solution Approach 2:
The patent changes the detection parameter from traditional absorbance or colorimetric signals to fluorescence resonance energy transfer signals. By using FRET between donor and acceptor fluorophores in antibody pairs, the system achieves high-throughput quantification through fluorescence microscopy or flow cytometry, transforming the detection paradigm from low-throughput manual methods to high-throughput automated fluorescence-based measurement
2Measurement precision
If Western blotting or ELISA methods are used to detect C3 and C3a, then detection capability is provided, but reliability is poor
Solution Approach 1:
The patent introduces FRET as an intermediary detection mechanism between the antibody-antigen binding event and signal generation. The FRET signal serves as a reliable intermediary that directly reports on the presence and concentration of C3 and C3a with high consistency, eliminating the variability and subjectivity inherent in manual Western blotting and ELISA methods
Solution Approach 2:
The patent substitutes unreliable manual detection methods with an automated FRET-based fluorescence detection system that provides consistent, reproducible results. The fluorescence signal from FRET pairs offers superior reliability compared to traditional methods, enabling accurate quantification of complement activity in complex biological samples
3Measurement precision
If traditional methods are used to study complement regulators, then detection is possible, but the process is laborious and time-consuming
Solution Approach 1:
The patent replaces time-consuming manual Western blotting procedures with rapid FRET-based fluorescence detection. The FRET assay can be performed in minutes using automated fluorescence microscopy or flow cytometry, reducing the time required for complement regulator detection from hours to minutes while maintaining detection capability
Solution Approach 2:
The patent enables continuous monitoring of complement activity through real-time FRET signal measurement. The FRET-based system allows continuous quantification of C3 consumption and C3a production over time, providing dynamic insights into complement regulation without the need for discrete, time-consuming endpoint analyses required by traditional methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a reliable and efficient means to measure C3 convertase activity and component production, facilitating the development of new drugs and biomarker discovery for complement-mediated diseases by offering a more accurate and efficient analysis of complement system processes.
Implementation Method 1
performing fluorescence resonance energy transfer (FRET) to detect the FRET signal
Data Source
AI summary
Provided herein are high throughput methods for measuring the protease activity of the complement C3 convertase by detecting the consumption of C3 or the production of C3a in vivo and in vitro.